These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19095729)

  • 1. Determinants of the acute-phase protein C-reactive protein in myocardial infarction survivors: the role of comorbidities and environmental factors.
    Rückerl R; Peters A; Khuseyinova N; Andreani M; Koenig W; Meisinger C; Dimakopoulou K; Sunyer J; Lanki T; Nyberg F; Schneider A
    Clin Chem; 2009 Feb; 55(2):322-35. PubMed ID: 19095729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromes.
    Biasucci LM; Liuzzo G; Della Bona R; Leo M; Biasillo G; Angiolillo DJ; Abbate A; Rizzello V; Niccoli G; Giubilato S; Crea F
    Clin Chem; 2009 Feb; 55(2):365-8. PubMed ID: 19179271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Inflammatory Markers and Health Status Among Young Adults With Acute Myocardial Infarction: Results From the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients) Study.
    Lu Y; Zhou S; Dreyer RP; Spatz ES; Geda M; Lorenze NP; D'Onofrio G; Lichtman JH; Spertus JA; Ridker PM; Krumholz HM
    Circ Cardiovasc Qual Outcomes; 2017 Feb; 10(2):e003470. PubMed ID: 28228461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction.
    Al Aseri ZA; Habib SS; Marzouk A
    Vasc Health Risk Manag; 2019; 15():221-227. PubMed ID: 31410012
    [No Abstract]   [Full Text] [Related]  

  • 5. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients.
    Fu EL; Franko MA; Obergfell A; Dekker FW; Gabrielsen A; Jernberg T; Carrero JJ
    Am Heart J; 2019 Oct; 216():20-29. PubMed ID: 31382219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study.
    Carrero JJ; Andersson Franko M; Obergfell A; Gabrielsen A; Jernberg T
    J Am Heart Assoc; 2019 Jun; 8(11):e012638. PubMed ID: 31140334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
    Mani P; Puri R; Schwartz GG; Nissen SE; Shao M; Kastelein JJP; Menon V; Lincoff AM; Nicholls SJ
    JAMA Cardiol; 2019 Apr; 4(4):314-320. PubMed ID: 30840024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility in serial C-reactive protein and interleukin-6 measurements in post-myocardial infarction patients: results from the AIRGENE study.
    Karakas M; Baumert J; Greven S; Rückerl R; Peters A; Koenig W
    Clin Chem; 2010 May; 56(5):861-4. PubMed ID: 20299677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Air pollution and inflammatory response in myocardial infarction survivors: gene-environment interactions in a high-risk group.
    Peters A; Schneider A; Greven S; Bellander T; Forastiere F; Ibald-Mulli A; Illig T; Jacquemin B; Katsouyanni K; Koenig W; Lanki T; Pekkanen J; Pershagen G; Picciotto S; Rückerl R; Rosario AS; Stefanadis C; Sunyer J;
    Inhal Toxicol; 2007; 19 Suppl 1():161-75. PubMed ID: 17886064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRP levels are higher in patients with ST elevation than non-ST elevation acute coronary syndrome.
    Habib SS; Kurdi MI; Al Aseri Z; Suriya MO
    Arq Bras Cardiol; 2011 Jan; 96(1):13-7. PubMed ID: 21152699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.
    Yip HK; Hang CL; Fang CY; Hsieh YK; Yang CH; Hung WC; Wu CJ
    Chest; 2005 Mar; 127(3):803-8. PubMed ID: 15764760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
    Zebrack JS; Anderson JL; Maycock CA; Horne BD; Bair TL; Muhlestein JB;
    Am J Cardiol; 2002 Jan; 89(2):145-9. PubMed ID: 11792332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins modulate feedback regulation mechanisms between advanced glycation end-products and C-reactive protein: evidence in patients with acute myocardial infarction.
    Paradela-Dobarro B; Raposeiras-Roubín S; Rodiño-Janeiro BK; Grigorian-Shamagian L; García-Acuña JM; Aguiar-Souto P; Jacquet-Hervet M; Reino-Maceiras MV; González-Juanatey JR; Alvarez E
    Eur J Pharm Sci; 2013 Jul; 49(4):512-8. PubMed ID: 23665412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors.
    Rückerl R; Greven S; Ljungman P; Aalto P; Antoniades C; Bellander T; Berglind N; Chrysohoou C; Forastiere F; Jacquemin B; von Klot S; Koenig W; Küchenhoff H; Lanki T; Pekkanen J; Perucci CA; Schneider A; Sunyer J; Peters A;
    Environ Health Perspect; 2007 Jul; 115(7):1072-80. PubMed ID: 17637925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acute myocardial infarction.
    Makrygiannis SS; Ampartzidou OS; Zairis MN; Patsourakos NG; Pitsavos C; Tousoulis D; Prekates AA; Foussas SG; Cokkinos DV
    Am J Cardiol; 2013 Jan; 111(1):26-30. PubMed ID: 23040593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.
    Moura FA; Figueiredo VN; Teles BS; Barbosa MA; Pereira LR; Costa AP; Carvalho LS; Cintra RM; Almeida OL; Quinaglia E Silva JC; Nadruz Junior W; Sposito AC;
    Atherosclerosis; 2015 Nov; 243(1):124-30. PubMed ID: 26385505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between the level of high-sensitivity C-reactive protein and cardiovascular risk factors in Korean adults with cardiovascular disease or diabetes mellitus: the CALLISTO study.
    Seo SM; Baek SH; Jeon HK; Kang SM; Kim DS; Kim WS; Kim HS; Rha SW; Park JS; Seong IW; Ahn YK; Yoon JH; Cha TJ
    J Atheroscler Thromb; 2013; 20(7):616-22. PubMed ID: 23676341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction.
    Hadjadj S; Coisne D; Mauco G; Ragot S; Duengler F; Sosner P; Torremocha F; Herpin D; Marechaud R
    Diabet Med; 2004 Apr; 21(4):305-10. PubMed ID: 15049930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of HbA1c and plasma glucose on one-year mortality in non-diabetic patients after myocardial infarction].
    Gueniat-Ratheau E; Yao H; Debeaumarche H; Maalem B; Lairet C; Maza M; Bichat F; Zeller M; N'Guetta R; Cottin Y
    Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):180-191. PubMed ID: 32854906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.
    Elkind MS; Leon V; Moon YP; Paik MC; Sacco RL
    Stroke; 2009 Oct; 40(10):3233-7. PubMed ID: 19644070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.